FDA.reportPublic FDA data

lidocaine 0.04 MG/MG / menthol 0.02 MG/MG / methyl salicylate 0.16 MG/MG Medicated Patch

RxCUI
1599163
RxNorm name
lidocaine 0.04 MG/MG / menthol 0.02 MG/MG / methyl salicylate 0.16 MG/MG Medicated Patch
Display name
Lidocaine/Menthol/Methyl salicylate (Topical)
Full name
lidocaine 0.04 MG/MG / menthol 0.02 MG/MG / methyl salicylate 0.16 MG/MG Medicated Patch
Term type
SCD
Status
Active
Strength
4-2-16%
Dose form
Medicated Patch
Route
Topical
Updated
2026-11-04 11:53:34

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022015
Active start
022015
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
methyl salicylate0.16 MG / 1 MGmethyl salicylatemethyl salicylate
lidocaine hydrochloride0.04 MG / 1 MGlidocainelidocaine
menthol0.02 MG / 1 MGmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Medicated Patch1792831

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
methyl salicylate29787
lidocaine6387
menthol6750

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRlidocaine 0.04 MG/MG / menthol 0.02 MG/MG / methyl salicylate 0.16 MG/MG Medicated Patch1NAMES
RxNorm Namelidocaine 0.04 MG/MG / menthol 0.02 MG/MG / methyl salicylate 0.16 MG/MG Medicated Patch1NAMES
RxNorm Synonymlidocaine 4 % / menthol 2 % / methyl salicylate 16 % Medicated Patch1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID093efd77-406f-2006-e054-00144ff88e881CODES
RxCUI15991631CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 4 matching rows.

NDC11, Source, Active table
NDC11SourceActive
69379001616rxnav_ndcsyes
62379001615rxnav_historical
69379001615rxnav_historical
69379001617rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
093efd77-406f-2006-e054-00144ff88e88lidocaine 4 % / menthol 2 % / methyl salicylate 16 % Medicated Patch [PSN] · lidocaine 0.04 MG/MG / menthol 0.02 MG/MG / methyl salicylate 0.16 MG/MG Medicated Patch [SCD] · lidocaine 4 % / menthol 2 % / methyl salicylate 16 % Medicated Patch [SY]31VELMA PAIN RELIEF PATCH20141202

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
093efd77-406f-2006-e054-00144ff88e88VELMA PAIN RELIEF PATCHHome Aide Diagnostics, Inc.20141202
0929689b-d902-5f1e-e054-00144ff8d46cVELMA PAIN RELIEF PATCHHome Aide Diagnostics, Inc.20141126
08b1dc5e-16df-3d48-e054-00144ff8d46cVELMA PAIN RELIEF PATCHHome Aide Diagnostics, Inc.20141118

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD012459SalicylatesCHEMhas_ingredientmethyl salicylate
MEDRTD059787Acute PainDISEASEmay_treatmethyl salicylate
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD001168ArthritisDISEASEmay_treatmethyl salicylate
MEDRTD001416Back PainDISEASEmay_treatmethyl salicylate
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD003288ContusionsDISEASEmay_treatmethyl salicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withmethyl salicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD007249InflammationDISEASEmay_treatmethyl salicylate
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009120Muscle CrampDISEASEmay_treatmethyl salicylate
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD013180Sprains and StrainsDISEASEmay_treatmethyl salicylate
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moamethyl salicylate
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moamethyl salicylate
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pemethyl salicylate
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_pemethyl salicylate
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESACTIVATED07/31/2023
ATTRIBUTESAVAILABLE_STRENGTH0.04 MG/MG / 0.02 MG/MG / 0.16 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESVUID4034004
NAMESPrescribable Synonymlidocaine 4 % / menthol 2 % / methyl salicylate 16 % Medicated Patch
SOURCESSourceMetathesaurus FDA Structured Product Labels